Phase II Trial of Neoadjuvant Nivolumab with Cisplatin a

Project: Research project

Project Details

Description

Phase II Trial of Neoadjuvant Nivolumab with Cisplatin and Gemcitabine in Muscle-Invasive Bladder Cancer (MIBC) Patients undergoing Radical Cystectomy
StatusActive
Effective start/end date5/1/1711/12/27

Funding

  • BRISTOL-MYERS SQUIBB COMPANY

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.